Correlation Between Verastem and Hepion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Verastem and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verastem and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verastem and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Verastem and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verastem with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verastem and Hepion Pharmaceuticals.
Diversification Opportunities for Verastem and Hepion Pharmaceuticals
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Verastem and Hepion is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Verastem and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Verastem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verastem are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Verastem i.e., Verastem and Hepion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Verastem and Hepion Pharmaceuticals
Given the investment horizon of 90 days Verastem is expected to generate 1.79 times more return on investment than Hepion Pharmaceuticals. However, Verastem is 1.79 times more volatile than Hepion Pharmaceuticals. It trades about 0.19 of its potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest 374.00 in Verastem on August 31, 2024 and sell it today you would earn a total of 83.00 from holding Verastem or generate 22.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Verastem vs. Hepion Pharmaceuticals
Performance |
| Timeline |
| Verastem |
| Hepion Pharmaceuticals |
Verastem and Hepion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verastem and Hepion Pharmaceuticals
The main advantage of trading using opposite Verastem and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verastem position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.| Verastem vs. Cue Biopharma | Verastem vs. Eliem Therapeutics | Verastem vs. Inhibrx | Verastem vs. Molecular Partners AG |
| Hepion Pharmaceuticals vs. Cue Biopharma | Hepion Pharmaceuticals vs. Eliem Therapeutics | Hepion Pharmaceuticals vs. Inhibrx | Hepion Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |